Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cargnel

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Infection|May 1, 1985
Attempted treatment of fulminant viral hepatitis with human fibroblast interferonF Milazzo, M Galli, P G Fassio, et al.
Infection|April 23, 2010
Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrantsG Orlando, S Merli, L Cordier, et al.
The Journal of Infectious Diseases|December 1, 1995
Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimensC Atzori, J J Lu, B Jiang, et al.
Current HIV Research|July 16, 2009
Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infectionE Angeli, A Mainini, A Cargnel, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1985
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in ItalyA R Zanetti, P Ferroni, M Colombo, et al.
Journal of Medical Virology|May 1, 1989
Pre-S proteins in hepatitis BL Kuijpers, M Koens, I Murray-Lyon, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
HIV Medicine|June 13, 2002
Adherence to HIV treatment: results from a 1-year follow-up studyM Martini, S D'Elia, F Paoletti, et al.
HIV Medicine|September 17, 2004
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevationP Meraviglia, M Schiavini, A Castagna, et al.
AIDS Patient Care and Stds|January 7, 2005
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patientsC Torti, E Quiros-Roldan, V Tirelli, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Infection|May 1, 1985
Attempted treatment of fulminant viral hepatitis with human fibroblast interferonF Milazzo, M Galli, P G Fassio, et al.
Infection|April 23, 2010
Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrantsG Orlando, S Merli, L Cordier, et al.
The Journal of Infectious Diseases|December 1, 1995
Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimensC Atzori, J J Lu, B Jiang, et al.
Current HIV Research|July 16, 2009
Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infectionE Angeli, A Mainini, A Cargnel, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1985
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in ItalyA R Zanetti, P Ferroni, M Colombo, et al.
Journal of Medical Virology|May 1, 1989
Pre-S proteins in hepatitis BL Kuijpers, M Koens, I Murray-Lyon, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
HIV Medicine|June 13, 2002
Adherence to HIV treatment: results from a 1-year follow-up studyM Martini, S D'Elia, F Paoletti, et al.
HIV Medicine|September 17, 2004
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevationP Meraviglia, M Schiavini, A Castagna, et al.
AIDS Patient Care and Stds|January 7, 2005
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patientsC Torti, E Quiros-Roldan, V Tirelli, et al.
Pageof 7